SecBot SecBot
SECBOTREPLAY Home › Report › COLL

COLL · Collegium Pharmaceutical won partial dismissal of Walgreens'…

COLLEGIUM PHARMACEUTICAL, INC · COURT-RULING filed Aug 18, 2026 at 20:00 ET

At the news

MIXEDIMPACT 5/10

COURT-RULING filed Aug 18, 2026 at 20:00 ET

Collegium Pharmaceutical won partial dismissal of Walgreens' breach-of-contract lawsuit in Massachusetts federal court. The court dismissed Walgreens' breach of contract and implied covenant claims (Counts I and II) with prejudice, finding no contractual relationship existed between the parties. However, Walgreens' unjust enrichment claim (Count IV) and Massachusetts Chapter 93A unfair/deceptive trade practices claim (Count III) survived the motion to dismiss, with Walgreens seeking $14.3 million in damages for allegedly delayed product returns. The case proceeds on these two claims, creating ongoing litigation risk but removing the most direct contractual liability exposure.

  • Court dismissed breach of contract (Count I) and implied covenant (Count II) claims against Collegium, finding no enforceable contract existed between Walgreens and Collegium.
  • Walgreens' unjust enrichment claim (Count IV) survived, alleging Collegium retained $14,321,229.99 in value from products Walgreens could not return due to delayed Form 222 authorizations.
  • Walgreens' Chapter 93A unfair/deceptive trade practices claim (Count III) survived the motion to dismiss.
  • The case was originally filed in June 2025 in Illinois, dismissed for lack of personal jurisdiction in February 2026, and refiled in Massachusetts in March 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access